News

There is no clinically meaningful differences in safety and efficacy between biologics and biosimilars.

Guselkumab is being studied as a treatment for both Crohn's disease and ulcerative colitis.

The data presented during ECCO 2022 involved IBD patients both in Hong Kong and the US.

There is concerns over missed early screenings for gastrointestinal cancers due to the COVID-19 pandemic.

Dupilumab did not reach statistical significance in interim analysis despite numeric improvements being observed across key endpoints.

The efficacy rates at weeks 12 and 52 were numerically lower in ileal only Crohn’s disease relative to colonic only and ileal-colonic.

A higher proportion of patients treated with mirikizumab achieved clinical remission at week 12 compared to placebo.

Rare disease pyruvate kinase deficiency received first approved disease-modifying therapy.

Data show fewer than 1 in 20 patients with diabetes and ASCVD were prescribed a high-intensity statin, either an ACEI or ARB, and either an SGLT2I and/or a GLP-1RA.

The United Nations 2030 Agenda for Sustainable Development has called for an end to violence against women in its Sustainable Development Goals.

Sage Therapeutics and Biogen expect to apply to the FDA in 2022.

Prior to the ISS, there was no known scale to measure ichthyosis severity across the entire body.

The percentage of time with glucose level in the target range was 8.7 percentage points higher during the closed-loop period compared to control.

The number of dropouts and dropouts because of adverse events did not differ between treatments.

Retrospective cohort data show older veteran patients have generally a 20% reduced risk of 30-day mortality when treated for emergent care at a VA hospital.

Brain development could be impaired due to iron deficiencies, leading to an increased risk of ADHD.

Findings from REDUCE-IT show icosapent ethyl was projected to be cost-effective compared with standard care in patients with high CV risk despite statin therapy.

Data pooled from 5 trials show a consistent and manageable safety profile for continued treatment with PALFORZIA.

A 3-part series on the manifestations of physician burnout, how COVID-19 changed its scope and revealed systemic fractures, and finally, the path towards resolution and reformation.

Previous research indicated that the worsening of different inflammatory cutaneous diseases had been associated with exposure to air pollution.

Despite this, alexithymia was significantly associated with impaired quality of life and increased stigmatization levels in young students with acne.

Intravenous tramadol, developed by Avenue Therapeutics, fails to attain FDA approval as treatment for acute pain in adults.

An Israel cohort analysis suggests a "hybrid" of natural and vaccine-induced immunity is associated with the rare likelihood of SARS-CoV-2 reinfection.

The new hospital featured 50% private rooms, as well as regular cleaning and other preventative measures for C difficile infections.

Data showed that the greatest improvement before and after acne care was achieved after medical treatment by a dermatologist.

Califf previously served as FDA commissioner under the Obama Administration after a 35-year career at Duke University.

Dr. Yeung and colleagues offer insights into treating transmasculine patients who develop acne after gender-affirming testosterone therapy

A pilot trial suggests telemedicine methods need to be tailored to reach adversely affected populations including Black patients on Medicare or Medicaid.